Skip to main content
Watch Insiders
Market intelligence
OTLKHealthcare

Outlook Therapeutics Inc insider activity

In the last 90 days, 6 corporate insiders purchased $10,267,775 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$10,267,775
Corporate buyers
6
Latest transaction
Jun 2, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 2, 2026Yezan Munther HaddadinCorporate insiderOpen Market Purchase29,000$0.83$24,145
May 28, 2026Ghiath M. SukhtianDirector / 10% OwnerOpen Market Purchase8,539,709$0.59$5,000,000
May 28, 2026Ventures & Investments GmsDirector / 10% OwnerOpen Market Purchase8,539,709$0.59$5,000,000
Subscribe to see more data